glp 1 fridays Compounded Tirzepatide (GLP-1/GIP) Fridays - We do things

The economics of GLP-1s have undergone several heavy-duty studies and overviews, including one in October 2024 by the U.S

This perspective explores the practice implications for managing patients living with obesity and/or diabetes who are taking GLP-1 agonists by describing the impact of GLP-1 agonists

After both renal and hepatic evaluations, it was concluded that no hepatic or renal dosing adjustments are necessary with liraglutide

This shapes what we show you at the end

The reason I did this is that theres a tricky little bitch called NEAT, which can impact energy needs way more from person to person, especially when bulking